COVID-19

Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, share insights regarding COVID-19 potentially achieving endemic status.

COVID-19 bivalent booster uptake has been very sluggish, even though the booster provides better protection against newer variants. What can pharmacists and their teams do to improve booster rates?

Findings by researchers at Epic, the electronic health record company, show that the benefits extend to people ages 50-64.

Although few cultures showed bacterial coinfections, many children were given antibiotics.

Additional research is needed to fully understand the scope of Long COVID.

Moderna’s bivalent mRNA COVID-19 booster reached prespecified superiority and noninferiority criteria against multiple strains of SARS-CoV-2.

The Omicron variant radically changed reinfection rates.

A selection of the latest COVID-19 vaccine research out of IDWeek 2022.

Adults who receive influenza and pneumococcal vaccines may be more likely to receive COVID-19 vaccines and boosters.

The authorization offers another COVID-19 booster choice for adults.

Viral coinfections may become more common as COVID-19 restrictions continue to relax.

A new study shows the AD drug does not interfere with vaccinations or increase severity.

The emergency use authorization amendments extend availability of the bivalent booster to young children.

The benefits of COVID-19 vaccines for children, safety considerations, and the need to urge caregivers to get their children vaccinated.

Study links discrepancy to adults’ misbeliefs about vaccine safety

Data from periods of Delta and Omicron variant predominance were evaluated in a retrospective cohort study.

In a recent study, participants who had received a COVID-19 vaccine saw an average increase in menstrual cycle length of less than 1 day.

Two new studies offer conflicting results.

Congress could overrule presidential declaration, but White House threatened veto of similar measure in March.

World Health Organization said there is a lack of evidence of clinical effectiveness of the monoclonal antibodies Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating.

In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.

Infants of fully vaccinated mothers had fewer cases of hospitalization from COVID-19 than those unvaccinated.

William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children of all ages and describes what is on the horizon for RSV.

At-home COVID-19 testing is convenient, but impacts the number of reported cases. Could a digital tool help improve reporting to public health agencies?